Mamozol tab 2.5mg(30’s) Letrozole
Mamozol is an aromatic inhibitor to treat postmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer right after surgery (or possibly chemotherapy and radiation) to reduce the risk of the cancer coming back. Mamozol lowers the levels of the female sex hormone oestrogen in the body. Oestrogen stimulates some breast cancers to grow. These breast cancers are called hormone sensitive or hormone receptor positive. Mamozol can stop or slow the growth of these cancers.
Breast Cancer on the Rise: Over the last 50 years Breast Cancer has become a major problem, affecting many as one in eight women.
The Risk continues: Even after the surgery the risk of, hormone receptor positive Breast Cancer, return is ongoing. It has been recognized that approximately one third of all Breast Cancer are Oestrogen dependant and will regress after oestrogen deprivation.
MAMOZOL helps by inhibiting Oestrogen Biosynthesis : Letrozole (Mamozol) is US FDA approved first line treatment, of postmenopausal women with hormone receptor positive and hormone receptor unknown locally advanced or metastatic Breast Cancer
♦ Mamozol at the Dose of 5mg/day produces higher pregnancy rates and more mature follicles in women.
♦ Increased Pregnancy rates and low multiple gestation rates for ovulation induction.
le 300% safer than Clomiphene Citrate.
♦ Mamozol increases uterine blood flow.
4 Mamozol gives higher pregnancy rates and induces ovulation in women with PCOS.
MRP Rs. 6000/:
Only logged in customers who have purchased this product may leave a review.